Liminatus Pharma (LIMN) Payables (2024 - 2026)
Liminatus Pharma (LIMN) posted Payables of $2.0 million for Q1 2026, down 2.59% sequentially from $2.0 million in Q4 2025, and up 338.28% YoY from $450000.0 in Q1 2025.
Liminatus Pharma (LIMN) Payables (2024 - 2026) Analysis & Trends
Liminatus Pharma has reported Payables for 3 years, with the latest figure at $2.0 million in Q1 2026.
- Quarterly Payables rose 338.28% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 338.28% YoY) and the FY2025 annual result came in at $2.0 million, down 90.56% from the prior year.
- Payables eased to $2.0 million in Q1 2026 per LIMN's latest filing, from $2.0 million in the prior quarter.
- Over five years, Payables peaked at $21.5 million in Q4 2024 and troughed at $450000.0 in Q1 2025.
- A 3-year average of $4.4 million and a median of $2.0 million in 2025 frame the typical range for Payables.
- The sharpest annual moves came in 2025 and 2026: Payables plunged 90.56% in 2025, then soared 338.28% in 2026.
- Over 3 years, Payables stood at $21.5 million in 2024, then slumped by 90.56% to $2.0 million in 2025, then decreased by 2.59% to $2.0 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $2.0 million, $2.0 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - | 35.57 Mn |
| 10 | Liminatus Pharma | 253.13 Mn | 253.13 Mn | - | 2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 450,000.00 |
| Dec 31, 2024 | 21.46 Mn |
| Sep 30, 2024 | 2.80 Mn |
| Jun 30, 2024 | 2.80 Mn |